Lataa...
Bayesian adaptive randomization trial of intravenous ketamine for veterans with late-life, treatment-resistant depression
More than eleven million U.S. Veterans are at least 65 years of age, an age group of which almost 20% suffers from clinically significant depressive symptoms. Available pharmacological treatments are suboptimal for patients, including veterans, with late-life depression. Ketamine has emerged as a po...
Tallennettuna:
| Julkaisussa: | Contemp Clin Trials Commun |
|---|---|
| Päätekijät: | , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Elsevier
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6727003/ https://ncbi.nlm.nih.gov/pubmed/31508531 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.conctc.2019.100432 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|